FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

William McGuire

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Drug Resistance, Neoplasm

Co-author Network

Publications

TOP 3
William E Winter; G Larry Maxwell; Chunqiao Tian; Jay W Carlson; Robert F Ozols; Peter G Rose; Maurie Markman; Deborah K Armstrong; Franco Muggia; William P McGuire
Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Michael Seiden; Alan N Gordon; Diane C Bodurka; Ursula Matulonis; Richard T Penson; Eddie Reed; Dave S Alberts; Garry Weems; Michael Cullen; William P McGuire
A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer.
Maurie Markman; Alan N Gordon; William P McGuire; Franco M Muggia
Liposomal anthracycline treatment for ovarian cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of William McGuire (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: William E Winter; G Larry Maxwell; Chunqiao Tian; Jay W Carlson; Robert F Ozols; Peter G Rose; Maurie Markman; Deborah K Armstrong; Franco Muggia; William P McGuire
Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3621-7.
2006: Michael Seiden; Alan N Gordon; Diane C Bodurka; Ursula Matulonis; Richard T Penson; Eddie Reed; Dave S Alberts; Garry Weems; Michael Cullen; William P McGuire
A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer.
Gynecologic oncology 2006;101(1):55-61.
2004: Maurie Markman; Alan N Gordon; William P McGuire; Franco M Muggia
Liposomal anthracycline treatment for ovarian cancer.
Seminars in oncology 2004;31(6 Suppl 13):91-105.
2003: David H Moore; James Donnelly; William P McGuire; Lois Almadrones; David Cella; Thomas J Herzog; Steven E Waggoner
Limited access trial using amifostine for protection against cisplatin- and three-hour paclitaxel-induced neurotoxicity: a phase II study of the Gynecologic Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(22):4207-13.
2003: Stephen A Cannistra; Robert C Bast; Jonathan S Berek; Michael A Bookman; Christopher P Crum; Paul D DePriest; Judy E Garber; Wui-Jin Koh; Maurie Markman; William P McGuire; Peter G Rose; Eric K Rowinsky; Gordon J S Rustin; Steven J Skates; Paul A Vasey; Laura King
Progress in the management of gynecologic cancer: consensus summary statement.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(10 Suppl):129s-132s.
2001: Paula M Fracasso; Mark F Brady; David H Moore; J L Walker; Peter G Rose; L Letvak; T M Grogan; William P McGuire
Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: a gynecologic oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(12):2975-82.
2001: Gini F Fleming; Jeffrey M Fowler; Steven E Waggoner; Larry J Copeland; Benjamin E Greer; Ira R Horowitz; G Sutton; Russell J Schilder; Paula M Fracasso; H G Ball; William P McGuire
Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1021-9.
2000: Gini F Fleming; B J Roth; S D Baker; GP Sutton; Katherine Y Look; F M Muggia; Paula M Fracasso; William P McGuire
Phase I trial of paclitaxel and etoposide for recurrent ovarian carcinoma: a Gynecologic Oncology Group Study.
American journal of clinical oncology 2000;23(6):609-13.
2000: Peter G Rose; M Rodriguez; Steven E Waggoner; Benjamin E Greer; Ira R Horowitz; Jeffrey M Fowler; William P McGuire
Phase I study of paclitaxel, carboplatin, and increasing days of prolonged oral etoposide in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(16):2957-62.
2000: J S Berek; Kamma Bertelsen; Andreas du Bois; Mark F Brady; J Carmichael; Elizabeth A Eisenhauer; M Gore; S Grenman; TC Hamilton; Steen W Hansen; P G Harper; G Horvath; SB Kaye; H J Lück; B Lund; William P McGuire; JP Neijt; Robert F Ozols; M K B Parmar; M J Piccart-Gebhart; R van Rijswijk; P Rosenberg; Gordon J S Rustin; C Sessa; J Tate Thigpen; C Tropé; MK Tuxen; I Vergote; J B Vermorken; P H Willemse
[Epithelial ovarian cancer (advanced stage): consensus conference (1998)].
Gynécologie, obstétrique & fertilité 2000;28(7-8):576-83.
2000: William P McGuire; John A Blessing; Michael A Bookman; Samuel S Lentz; Charles J Dunton
Topotecan has substantial antitumor activity as first-line salvage therapy in platinum-sensitive epithelial ovarian carcinoma: A Gynecologic Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(5):1062-7.
1999: JA Bridgewater; Ann Nelstrop; Gordon J S Rustin; M E Gore; William P McGuire; W J Hoskins
Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):501-8.
1999: J S Berek; Kamma Bertelsen; Andreas du Bois; Mark F Brady; J Carmichael; Elizabeth A Eisenhauer; M Gore; S Grenman; TC Hamilton; Steen W Hansen; P G Harper; G Horvath; SB Kaye; H J Lück; B Lund; William P McGuire; JP Neijt; Robert F Ozols; M K B Parmar; M J Piccart-Gebhart; R van Rijswijk; P Rosenberg; Gordon J S Rustin; C Sessa; P H Willemse
Advanced epithelial ovarian cancer: 1998 consensus statements.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10 Suppl 1():87-92.
1999: William P McGuire; Mark F Brady; Robert F Ozols
The Gynecologic Oncology Group experience in ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10 Suppl 1():29-34.
1998: Thomas E Keane; Rizk El-Galley; C Sun; John Petros; D Dillahey; A Gomaa; SD Graham; William P McGuire
Camptothecin analogues/cisplatin: an effective treatment of advanced bladder cancer in a preclinical in vivo model system.
The Journal of urology 1998;160(1):252-6.
1998: William P McGuire; Robert F Ozols
Chemotherapy of advanced ovarian cancer.
Seminars in oncology 1998;25(3):340-8.
1998: Maurie Markman; Peter G Rose; E Jones; Ira R Horowitz; A Kennedy; Kenneth Webster; Jerome Belinson; Nancy Fusco; L Fluellen; Barbara Kulp; Gertrude Peterson; William P McGuire
Ninety-six-hour infusional paclitaxel as salvage therapy of ovarian cancer patients previously failing treatment with 3-hour or 24-hour paclitaxel infusion regimens.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1849-51.
1997: William P McGuire; W J Hoskins; Mark F Brady; P R Kucera; Edward E Partridge; Katherine Y Look; Daniel L Clarke-Pearson; M Davidson
Comparison of combination therapy with paclitaxel and cisplatin versus cyclophosphamide and cisplatin in patients with suboptimal stage III and stage IV ovarian cancer: a Gynecologic Oncology Group study.
Seminars in oncology 1997;24(1 Suppl 2):S2-13-S2-16.
1997: S O'Reilly; Gini F Fleming; S D Barker; JANET WALCZAK; Michael A Bookman; William P McGuire; Russell J Schilder; R D Alvarez; Deborah K Armstrong; Ira R Horowitz; Robert F Ozols; Eric K Rowinsky
Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):177-86.
1996: William P McGuire; William J Hoskins; Mark F Brady; P R Kucera; Edward E Partridge; K Y Look; Daniel L Clarke-Pearson; M Davidson
Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group).
Seminars in oncology 1996;23(5 Suppl 12):40-7.
1996: William P McGuire; J A Blessing; D Moore; S S Lentz; G Photopulos
Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(3):792-5.
1996: William P McGuire; William J Hoskins; Mark F Brady; P R Kucera; Edward E Partridge; K Y Look; Daniel L Clarke-Pearson; M Davidson
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.
The New England journal of medicine 1996;334(1):1-6.
1995: Tate Thigpen; R B Vance; William P McGuire; William J Hoskins; M Brady
The role of paclitaxel in the management of coelomic epithelial carcinoma of the ovary: a review with emphasis on the Gynecologic Oncology Group experience.
Seminars in oncology 1995;22(6 Suppl 14):23-31.
1995: William P McGuire; William J Hoskins; Mark F Brady; Howard D Homesley; William T Creasman; M L Berman; H Ball; J S Berek; J Woodward
Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1589-99.
1993: Tate Thigpen; Mark F Brady; G A Omura; William T Creasman; William P McGuire; William J Hoskins; S Williams
Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience.
Cancer 1993;71(2 Suppl):606-14.